It may be the dose prescribed…the type of epilepsy you have…even something as simple as your age or weight.
But research shows that, over time, the effectiveness of your anti-epilepsy drug may decline.
The first Vagus Nerve Stimulator (VNS) was implanted in 1988, as a therapeutic option for medically intractable epilepsy, when elective epilepsy surgery was not appropriate.
As the number of implanted vagus nerve stimulators grows, so does the need to remove or revise the devices.
Which is a little tricky, because of the spiral stimulating electrodes, wrapped around the nerve.
Especially if the VNS treatment has proven ineffective.
And of course, what goes in, must come out.
Anyway you look at it, there’s more surgery involved.
Posted in
Epilepsy,
Medication Issues,
News,
ResearchTags:
alternative,
better seizure control,
depression reduction,
drug-resistant,
effective,
enhancement,
Epilepsy,
no side-effects,
no surgery,
non-invasive,
post traumatic stress,
success rate,
trigeminal nerve stimulation,
vagus nerve stimulator
When Keppra was approved as an add-on medicine for partial seizures, including partial seizures with secondary generalization, at the time, it was suggested that Keppra might have a universally positive effect on all seizure types.
That’s all fine and good for researchers who aren’t struggling with epilepsy every day. But here’s a random sampling of what real people – like you and me – have to say…
Posted in
Epilepsy,
Medication Issues,
TipsTags:
behavioral consequences,
controversy,
drug-resistant,
Epilepsy,
Keppra,
real people's stories,
the bad,
the good,
the ugly
It may be the dose prescribed…the type of epilepsy you have…even something as simple as your age or weight.
But research shows that, over time, the effectiveness of your anti-epilepsy drug may decline.